Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 1998, p. 2419-2422, Vol. 36, No. 9
Viral Hepatitis and AIDS Study
Group1 and
Department of
Microbiology,
Received 3 March 1998/Returned for modification 20 April
1998/Accepted 8 June 1998
The actual prevalence of visceral leishmaniasis among human
immunodeficiency type 1 (HIV-1)-infected patients in the Mediterranean basin remains unknown. There is also controversy about the risk factors
for Leishmania infantum and HIV-1 coinfection. To appraise the prevalence of visceral leishmaniasis in patients infected with
HIV-1 in southern Spain and to identify factors associated with this
disease, 291 HIV-1 carriers underwent a bone marrow aspiration,
regardless of their symptoms. Giemsa-stained samples were searched for
Leishmania amastigotes. Thirty-two (11%) patients showed
visceral leishmaniasis. Thirteen (41%) patients had subclinical cases
of infection. Centers for Disease Control and Prevention (CDC) clinical
category C was the factor most strongly associated with this disease
(adjusted odds ratio [OR], 1.88 [95% confidence interval, 1.22 to
2.88]), but patients with subclinical cases of infection were found in
all CDC categories. Female sex was negatively associated with visceral
leishmaniasis (adjusted OR, 0.42 [95% confidence interval, 0.18 to
0.97]). Intravenous drug users showed a higher prevalence than the
remaining patients (13.3 versus 4.9%; P = 0.04), but
such an association was not independent. These results show that
visceral leishmaniasis is a very prevalent disease among HIV-1-infected
patients in southern Spain, with a high proportion of cases being
subclinical. Like other opportunistic infections, subclinical visceral
leishmaniasis can be found at any stage of HIV-1 infection, but
symptomatic cases of infection appear mainly when a deep
immunosuppression is present. There is also an association of this
disease with male sex and intravenous drug use.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Prevalence of and Factors Associated with Visceral
Leishmaniasis in Human Immunodeficiency Virus Type 1-Infected
Patients in Southern Spain
*
Corresponding author. Mailing address: Viral Hepatitis
and AIDS Study Group, Hospital Universitario Virgen del Rocío,
Avenida Manuel Siurot s/n, 41013-Sevilla, Spain. Phone: 34-5-4248154. Fax: 34-5-4248249. E-mail: vergara{at}cica.es.
Journal of Clinical Microbiology, September 1998, p. 2419-2422, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|